SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-022751
Filing Date
2016-08-04
Accepted
2016-08-04 17:11:25
Documents
65
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mack-10q_20160630.htm 10-Q 1833744
2 EX-31.1 mack-ex311_20.htm EX-31.1 9522
3 EX-31.2 mack-ex312_19.htm EX-31.2 9514
4 EX-32.1 mack-ex321_17.htm EX-32.1 5693
5 EX-32.2 mack-ex322_18.htm EX-32.2 5671
  Complete submission text file 0001564590-16-022751.txt   6570440

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mack-20160630.xml EX-101.INS 1407031
7 XBRL TAXONOMY EXTENSION SCHEMA mack-20160630.xsd EX-101.SCH 51112
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20160630_cal.xml EX-101.CAL 51946
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20160630_def.xml EX-101.DEF 158017
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20160630_lab.xml EX-101.LAB 378000
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20160630_pre.xml EX-101.PRE 291209
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 161808357
SIC: 2834 Pharmaceutical Preparations